Copyright Reports & Markets. All rights reserved.

Global Oral Cholera Vaccine Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Oral Cholera Vaccine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Oral Cholera Vaccine Market Size Growth Rate by Product
      • 1.4.2 Shanchol
      • 1.4.3 Dukoral
      • 1.4.4 Vaxchora
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Oral Cholera Vaccine Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Research & Academic Laboratories
      • 1.5.4 Pharmaceutical & Biotechnology Companies
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Oral Cholera Vaccine Market Size
      • 2.1.1 Global Oral Cholera Vaccine Revenue 2014-2025
      • 2.1.2 Global Oral Cholera Vaccine Sales 2014-2025
    • 2.2 Oral Cholera Vaccine Growth Rate by Regions
      • 2.2.1 Global Oral Cholera Vaccine Sales by Regions
      • 2.2.2 Global Oral Cholera Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Oral Cholera Vaccine Sales by Manufacturers
      • 3.1.1 Oral Cholera Vaccine Sales by Manufacturers
      • 3.1.2 Oral Cholera Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Oral Cholera Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oral Cholera Vaccine Revenue by Manufacturers
      • 3.2.1 Oral Cholera Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Cholera Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Oral Cholera Vaccine Price by Manufacturers
    • 3.4 Oral Cholera Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Oral Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Oral Cholera Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Oral Cholera Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Oral Cholera Vaccine Sales by Product
    • 4.2 Global Oral Cholera Vaccine Revenue by Product
    • 4.3 Oral Cholera Vaccine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Oral Cholera Vaccine Breakdown Data by End User

    6 North America

    • 6.1 North America Oral Cholera Vaccine by Countries
      • 6.1.1 North America Oral Cholera Vaccine Sales by Countries
      • 6.1.2 North America Oral Cholera Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Oral Cholera Vaccine by Product
    • 6.3 North America Oral Cholera Vaccine by End User

    7 Europe

    • 7.1 Europe Oral Cholera Vaccine by Countries
      • 7.1.1 Europe Oral Cholera Vaccine Sales by Countries
      • 7.1.2 Europe Oral Cholera Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Oral Cholera Vaccine by Product
    • 7.3 Europe Oral Cholera Vaccine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Oral Cholera Vaccine by Countries
      • 8.1.1 Asia Pacific Oral Cholera Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Oral Cholera Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Oral Cholera Vaccine by Product
    • 8.3 Asia Pacific Oral Cholera Vaccine by End User

    9 Central & South America

    • 9.1 Central & South America Oral Cholera Vaccine by Countries
      • 9.1.1 Central & South America Oral Cholera Vaccine Sales by Countries
      • 9.1.2 Central & South America Oral Cholera Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Oral Cholera Vaccine by Product
    • 9.3 Central & South America Oral Cholera Vaccine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Oral Cholera Vaccine by Countries
      • 10.1.1 Middle East and Africa Oral Cholera Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Oral Cholera Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Oral Cholera Vaccine by Product
    • 10.3 Middle East and Africa Oral Cholera Vaccine by End User

    11 Company Profiles

    • 11.1 PaxVax
      • 11.1.1 PaxVax Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 PaxVax Oral Cholera Vaccine Products Offered
      • 11.1.5 PaxVax Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Oral Cholera Vaccine Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Valneva
      • 11.3.1 Valneva Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Valneva Oral Cholera Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Valneva Oral Cholera Vaccine Products Offered
      • 11.3.5 Valneva Recent Development
    • 11.4 EuBiologics
      • 11.4.1 EuBiologics Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 EuBiologics Oral Cholera Vaccine Products Offered
      • 11.4.5 EuBiologics Recent Development

    12 Future Forecast

    • 12.1 Oral Cholera Vaccine Market Forecast by Regions
      • 12.1.1 Global Oral Cholera Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Oral Cholera Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Oral Cholera Vaccine Market Forecast by Product
      • 12.2.1 Global Oral Cholera Vaccine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Oral Cholera Vaccine Revenue Forecast by Product 2019-2025
    • 12.3 Oral Cholera Vaccine Market Forecast by End User
    • 12.4 North America Oral Cholera Vaccine Forecast
    • 12.5 Europe Oral Cholera Vaccine Forecast
    • 12.6 Asia Pacific Oral Cholera Vaccine Forecast
    • 12.7 Central & South America Oral Cholera Vaccine Forecast
    • 12.8 Middle East and Africa Oral Cholera Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Oral Cholera Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Oral Cholera Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Cholera Vaccine market based on company, product type, end user and key regions.

      This report studies the global market size of Oral Cholera Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Cholera Vaccine in these regions.
      This research report categorizes the global Oral Cholera Vaccine market by top players/brands, region, type and end user. This report also studies the global Oral Cholera Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      PaxVax
      Sanofi
      Valneva
      EuBiologics

      Market size by Product
      Shanchol
      Dukoral
      Vaxchora
      Others
      Market size by End User
      Hospital
      Research & Academic Laboratories
      Pharmaceutical & Biotechnology Companies
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Oral Cholera Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Oral Cholera Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Oral Cholera Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Oral Cholera Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Oral Cholera Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Cholera Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now